Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Health Canada has approved six medications specifically for chronic weight management: orlistat (Xenical), liraglutide (Saxenda), naltrexone-bupropion (Contrave), semaglutide (Wegovy), tirzepatide (Zepbound), and setmelanotide (Imcivree, for rare genetic forms of obesity only)
Patients who combine semaglutide with consistent strength training and adequate protein intake often see faster fat loss and better body composition than those relying on medication alone
1033729) provides the rigorous clinical governance necessary to manage these complex interactions safely
Waist size reductions deserve attention because they relate to fat around abdominal organs
providers typically recommend spacing it apart from GLP-1 doses by several hours
US$ 22.96
US$ 22.50
US$ 23.22
US$ 27.33
US$ 23.75
US$ 29.40
